Patients' interest in discussing cancer risk and risk management with primary care physicians

被引:12
作者
Buchanan, AH
Skinner, CS
Rawl, SM
Moser, BK
Champion, VL
Scott, LL
Strigo, TS
Bastian, L
机构
[1] Duke Univ, Med Ctr, Canc Prevent Detect & Control Res Program, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
[3] Indiana Univ, Sch Nursing, Indianapolis, IN 46202 USA
[4] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[6] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA
关键词
physician-patient communication; cancer risk; cancer screening; chemoprevention; genetic counseling;
D O I
10.1016/j.pec.2004.04.003
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Little is known about patients' preferences for discussing cancer risks and risk management with primary care physicians. We sought to determine whether patients want to discuss such topics and what factors are associated with this interest. Participants (375 patients ages 40-85, of diverse race and education level) completed a telephone survey prior to scheduled physician visits. Survey included items on perceived health, perceived cancer risk, education level, and whether participants would like to discuss with a physician their breast, ovarian or colon cancer risk, tamoxifen, cancer genetic counseling, and colon cancer screening. Greater proportions were interested in discussing risks for each cancer, compared with those who were not (P < 0.0001). More participants were interested in discussing mammograms (80%) and cancer genetic counseling (60%) than tarnoxifen (49%) or colon cancer screening modalities (43-53%). For many topics, poorer perceived health was associated with greater interest in future discussion; higher education level was associated with less interest. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:77 / 87
页数:11
相关论文
共 46 条
[1]  
*AM CANC SOC, 2003, CANC FACTS FIG AFR
[2]   Genetic counseling and testing for breast-ovarian cancer susceptibility: What do women want? [J].
Audrain, J ;
Rimer, B ;
Cella, D ;
Garber, J ;
Peshkin, BN ;
Ellis, J ;
Schildkraut, J ;
Stefanek, M ;
Vogel, V ;
Lerman, C .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) :133-138
[3]   Women's interest in chemoprevention for breast cancer [J].
Bastian, LA ;
Lipkus, IM ;
Kuchibhatla, MN ;
Weng, HH ;
Halabi, S ;
Ryan, PD ;
Skinner, CS ;
Rimer, BK .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (13) :1639-1644
[4]   Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[5]  
BROWN RI, 1999, SOC SCI MED, V43, P315
[6]   Colon cancer screening [J].
Burt, RW .
GASTROENTEROLOGY, 2000, 119 (03) :837-853
[7]   Information, support, and communication needs of women with a family history of breast cancer [J].
Chalmers, K ;
Thomson, K ;
Degner, LF .
CANCER NURSING, 1996, 19 (03) :204-213
[8]   BRCA1 - Lots of mutations, lots of dilemmas [J].
Collins, FS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :186-188
[9]   Validation studies for models projecting the risk of invasive and total breast cancer incidence [J].
Costantino, JP ;
Gail, MH ;
Pee, D ;
Anderson, S ;
Redmond, CK ;
Benichou, J ;
Wieand, HS .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (18) :1541-1548
[10]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388